JSR Life Sciences について
私たちのことを学ぶ
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.
JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.
Accelerating Our Life Sciences Footprint
We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.
Our Affiliates
We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.
Crown Bioscience
Contract research organization with advanced technology for precision medicine
Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.
MBL
Biomarker discovery for companion and in vitro diagnostics
KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities
JSR’s specialty life science research products include:
Amsphere A3, a protein A chromatography resin for advanced protein separation
Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use
JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.
最新の JSR Life Sciences ニュース
KBI Biopharmaが生物製剤製造での グローバルリーダーとして受賞
JSR ライフサイエンスの子会社である KBI Biopharma は、2025 CDMO リーダーシップ アワードでバイオ医薬品製造における卓越性に対して世界的に認められました。
Crown Bioscience、John Guを最高経営責任者に任命
クラウン・バイオサイエンスはジョン・グー氏を CEO に任命し、AI 主導の創薬における彼の専門知識を活用して、バイオテクノロジーの革新と世界の健康を推進します
Crown BioscienceがIndivumed Servicesとの合併を完了
Crown Bioscience は Indivumed Services の合併を完了し、強化された医薬品開発ソリューションを世界中に提供し、Indivumed ブランドを廃止します。